Why the study?
More advanced strategies for predicting risk stage in AF are needed, and the authors aimed to identify miRNAs with prognostic value associated with low-voltage area extent in patients referred for AF ablation.
Is plasma miR-486-5p expression associated with low-voltage area extent in patients with atrial fibrillation?
Is plasma miR-486-5p expression associated with low-voltage area extent in patients with atrial fibrillation?
Plasma miR-486-5p is upregulated in AF patients with broader low-voltage areas and may serve as a biomarker for atrial structural remodeling.
Answers are grounded in this paper and cite their sources.
miR-486-5p may refine pre-ablation risk stratification in AF; leaves open whether it improves outcomes or guides therapy.
Atrial fibrillation (AF) is the most common arrhythmia worldwide, affecting 1% of the population over 60 years old. The incidence and prevalence of AF are increasing globally, representing a relevant health problem, suggesting that more advanced strategies for predicting risk stage are highly needed. miRNAs mediate several processes involved in AF. Our aim was to identify miRNAs with a prognostic value as biomarkers in patients referred for AF ablation and its association with LVA extent, based on low-voltage area (LVA) maps. In this study, we recruited 44 AF patients referred for catheter ablation. We measured the expression of 84 miRNAs in plasma from peripheral blood in 3 different groups based on LVA extent. Expression analysis showed that miR-486-5p was significantly increased in patients with broader LVA (4-fold, p = 0.0002; 5-fold, p = 0.0001). Receiver operating characteristic curve analysis showed that miR-486-5p expression could predict atrium LVA (AUC, 0.8958; p = 0.0015). Also, miR-486-5p plasma levels were associated with AF-type (AUC, 0.7137; p = 0.0453). In addition, miR-486-5p expression was positively correlated with LVA percentage, left atrial (LA) area, and LA volume (r = 0.322, p = 0.037; r = 0.372, p = 0.015; r = 0.319, p = 0.045, respectively). These findings suggest that miR-486-5p expression might have prognostic significance in LVA extent in patients with AF.
No takes yet. Share an insight, caveat, or question.
Cebro-Márquez et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: